Tag Archives: Israel

UAE, Israel in talks to establish quarantine-free travel corridor

DUBAI (Reuters) – United Arab Emirates and Israel’s governments have entered formal talks to establish a quarantine-free travel corridor between the two countries to boost bilateral exchange following a normalization deal, state news agency WAM reported on Wednesday.

The travel corridor, which will apply to passengers who are fully vaccinated against COVID-19, will help facilitate travel for commercial, tourism and official purposes, state news agency WAM reported on Wednesday.

Israel established formal relations with the UAE and Bahrain last September as part of a U.S.-brokered agreement. The three countries share common concerns about Iran.

UAE and Israel are among the countries with the world’s fastest COVID-19 vaccination programs.

(Reporting by Nayera Abdullah in Cairo, writing by Marwa Rashad in London; Editing by Bernadette Baum)

Palestinian hospitals fill up as Israel loosens COVID-19 restrictions

By Zainah El-Haroun

RAMALLAH, West Bank (Reuters) – Palestinian hospitals are overfull and intensive-care units operating at 100% capacity with coronavirus patients in some areas of the Israeli-occupied West Bank, Prime Minister Mohammad Shtayyeh said on Tuesday.

Palestinian cities have introduced full lockdowns over the last two weeks to control soaring COVID-19 infections, even as neighboring Israel has begun to lift restrictions as it proceeds with one of the world’s fastest vaccination campaigns.

“The percentage of hospital occupancy in some areas has reached more than 100%,” Shtayyeh said in Ramallah, one of the West Bank cities where his Palestinian Authority (PA) exercises limited self-rule.

“The number of casualties is increasing and the number of deaths is increasing on a daily basis, forcing us to take strict, direct and unprecedented measures.”

The West Bank and Gaza, home to a combined 5.2 million Palestinians, have received around 34,700 vaccine doses to date. These came from small donations by Israel and Russia as well as 20,000 sent by the United Arab Emirates to Gaza.

Meanwhile in Israel, restaurants reopened on Sunday as the country kept up a fast pace of mass vaccinations.

“I brought millions of doses, now I’ll have to bring tens of millions of doses. I am currently in talks with Pfizer and Moderna to bring more,” Prime Minister Benjamin Netanyahu told Israel Army Radio, campaigning ahead of a March 23 election.

Israel has given 53% of its 9 million population at least one dose of the Pfizer/BioNTech COVID-19 vaccine, according to Health Ministry data, and 38% have received both doses.

The contrast has not gone unnoticed among Palestinians.

On Monday, Israel extended its vaccination program to include Palestinian laborers who work in Israel and in its West Bank settlements.

Many Palestinians argue that Israel is neglecting its obligations as an occupying power by not including them in the mass roll-out.

“The number of vaccinations in Israel is really high,” Saji Khalil, 75, told Reuters. “Even the Palestinian laborers whom they vaccinated, they did it to serve the Israeli community, not to look out for the well-being of the laborers.”

Israeli officials say that under the 1990s Oslo interim peace accords, the Palestinian Authority is responsible for vaccinating its population.

Many Palestinians are dissatisfied with their leaders. The PA came under fire from rights groups last week after admitting that it had sent 10% of the COVID-19 doses that it received to VIPs.

Firas Narawesh, from Ramallah, said the government had failed to provide vaccinations to ordinary Palestinians, and had “distributed vaccinations in an unfair way and in an unequal way with clear favoritism and corruption.”

(Additional reporting by Adel Abu Nimeh and Ismael Khader in Ramallah; Editing by Stephen Farrell and Mark Heinrich)

Gaza is open again, to the south. But for how long?

By Nidal al-Mughrabi

RAFAH, Gaza Strip (Reuters) – A fleet of yellow Mercedes taxis lines up outside Gaza’s newly reopened Rafah crossing into Egypt, polished again and ready to roll, but with no idea for how long.

Uncertainty is a fact of life in the Palestinian border town, where 4,500 people have crossed into Egypt in the two weeks since one of Gaza’s few lifelines to the outside world swung open on Feb. 9.

The opening eased the years-long blockade imposed by Israel and Egypt on the coastal strip, compounded by measures imposed by all sides to halt the spread of COVID-19.

It arose from political maneuvering: Egyptian-brokered mediation talks between rival Palestinian factions to smooth the way for possible elections.

But the travelers have no idea how long the gate will stay open.

“To me, Rafah crossing is my source of living. If it opens, I live, and I eat and buy clothes,” said Saif Rusrus, 21, who left school to sell pastries there. “As long as there are disputes, the crossing will continue to open and close.”

Israel and Egypt cite security concerns for the restrictions, pointing to the fact that Gaza is controlled by the Islamist militant group Hamas.

The two countries allow passage for thousands of workers and humanitarian cases each year, but most of Gaza’s two million Palestinians cannot leave.

“Gaza turns into a big prison when Rafah crossing is closed,” said hepatitis patient Uday Zaanin, 38, as he waited to board the bus.

(Reporting by Nidal Almughrabi in Rafah; Writing by Stephen Farrell in Jerusalem; Editing by Giles Elgood)

Israel aims to resolve Iran disputes with Biden at adviser level

By Dan Williams

JERUSALEM (Reuters) – Israel hopes to prevent personal tension between Prime Minister Benjamin Netanyahu and U.S. President Joe Biden over their differences on the Iranian nuclear question by delegating talks on the topic to their senior staff, an Israeli official said.

Netanyahu’s foreign-policy fortunes have waned since Biden succeeded Republican president Donald Trump, who withdrew the United States from world powers’ 2015 Iranian nuclear deal, deeming it too advantageous for Tehran – a view Israel shared.

Biden, a Democrat, wants to rejoin the deal. That has set the stage for possible new strains in the U.S.-Israel alliance.

On Monday, Netanyahu conferred with Defense Minister Benny Gantz and Foreign Minister Gabi Ashkenazi to present a united Israeli front on Iran – even as the conservative premier runs against the two centrists in a March election.

An official briefed on Monday’s meeting said it was agreed that Israeli misgivings about, and proposed improvements to, the deal would be relayed by Netanyahu’s National Security Council to the counterpart National Security Council in the White House.

“The intent is to work everything out at that level, and to keep that communication channel open,” the official told Reuters on Tuesday on condition on anonymity. “Obviously this has benefits where there is a risk of a ‘cold shoulder’ at chief-executive level.”

Citing unnamed sources involved in the meeting, Israel’s Army Radio reported the Netanyahu and the other ministers had decided to keep disputes with Biden “under the radar” for now.

Netanyahu’s office declined comment.

When the 2015 deal was being put together, Netanyahu’s opposition – including in a speech he delivered to the U.S. Congress – led to feuds with the then Democratic administration of Barack Obama, whom Biden served as vice president.

Netanyahu’s office said on Friday that Israel was “in close contact” with Washington on the issue and asserted that a return to the 2015 deal would “pave Iran’s path to a nuclear arsenal”.

Israel previously hinted it might shun Iran talks with Washington in the event of a new deal that it still opposes, lest such engagement give the impression of consent.

Iran, which denies seeking the bomb, began breaching the deal in 2019, following the U.S. withdrawal. It has recently stepped up violations and was cool to an administration announcement on Thursday that Washington was ready to talk about a mutual return to compliance.

Israel is reputed to have the region’s only nuclear arsenal, something it neither confirms nor denies under an “ambiguity” policy designed to ward off foes while avoiding arms races.

(Writing by Dan Williams, Editing by William Maclean)

Pfizer wants to store vaccine at higher temperatures, making deliveries easier

FRANKFURT (Reuters) – Pfizer Inc and BioNTech SE have asked the U.S. health regulator to relax requirements for their COVID-19 vaccine to be stored at ultra-low temperatures, potentially allowing it to be kept in pharmacy freezers, they said on Friday.

Approval by the Food and Drug Administration (FDA) could send a strong signal to other regulators around the world that may ease distribution of the shot in lower-income countries.

The companies have submitted new temperature data to the FDA to support an update to the current label that would allow vials to be stored at -25 to -15 degrees Celsius (-13°F to 5°F) for a total of two weeks.

The current label requires the vaccine to be stored at temperatures between -80ºC and -60ºC (-112ºF to -76ºF), meaning it has to be shipped in specially designed containers.

The shot’s cold-storage requirements set off a scramble among U.S. states at the beginning of the rollout for dry ice, in which it can be stored temporarily when there are no specialized freezers available, for instance in rural areas.

Amesh Adalja, senior scholar at the Johns Hopkins Center for Health Security, said the higher temperatures should “greatly expand the ability to use this vaccine in many parts of the world (or even the U.S.) that do not have the capacity for deep freeze storage”.

Pfizer/BioNTech’s vaccine, along with Moderna Inc’s two-dose shot, has already won U.S. emergency-use authorization and is being widely distributed as part of the country’s mass vaccination efforts.

The update from the drugmakers comes as two studies from Israel found that the vaccine greatly reduced virus transmission, and the shot was backed by two of the South African government’s top advisers.

The new data also will be submitted to global regulatory agencies within the next few weeks, the two companies said.

A BioNTech spokeswoman declined to provide more details on the timing and which agencies would be contacted.

“The data submitted may facilitate the handling of our vaccine in pharmacies and provide vaccination centers an even greater flexibility,” BioNTech Chief Executive Ugur Sahin said.

Deutsche Post, which has shipped COVID-19 vaccines to several European countries, Israel, Bahrain, Mexico and Singapore, among other states, said -25 degrees would provide some relief but transportation would still not be easy.

A spokeswoman said air freight would likely no longer require dry ice on board, increasing storage capacity per plane.

BioNTech has said it imposed long-term storage and transportation requirements of -70 degrees out of caution because it had started stability and durability tests on its vaccine relatively late.

Even though it launched its COVID-19 vaccine development program as early as January 2020, working on four compounds in parallel, it did not decide until July which of the four to proceed with, and only then started stability tests.

If approved, the less onerous storage requirements would provide significant logistical relief.

The World Health Organization’s COVAX global vaccine-sharing program has so far limited distribution of Pfizer-BioNTech vaccines to just a few countries, partly out of concern over a lack of infrastructure in developing nations.

The WHO said it was hopeful that eased requirements could broaden its reach.

“We are aware of reports of this and look forward to seeing the data. If proven correct, this could make rollout of the vaccine easier in all countries, and particularly in low-income ones,” it said.

Moderna’s product, which like Pfizer’s is based on so-called messenger RNA molecules, is already cleared for storage at -25 to -15 degrees Celsius.

(Reporting by Manojna Maddipatla and Ankur Banerjee in Bengaluru, Ludwig Burger in Frankfurt, John Miller in Zurich, Matthias Inverardi in Duesseldorf, Michael Erman in Maplewood, N.J. and Lisa Baertlein in Los Angeles; Editing by Shounak Dasgupta, Anil D’Silva, Jan Harvey and Nick Macfie)

International Criminal Court rules it has jurisdiction over Palestinian territories

By Toby Sterling and Stephanie van den Berg

THE HAGUE (Reuters) – The International Criminal Court ruled on Friday that it has jurisdiction over war crimes or atrocities committed in the Palestinian Territories, paving the way for a criminal investigation, despite Israeli objections.

The decision prompted swift reactions from both Israel, which is not a member of the court and again rejected its jurisdiction, and the Palestinian Authority, which welcomed the ruling.

The ICC judges said their decision was based on rules in the Hague-based court’s founding documents and does not imply any attempt to determine statehood or legal borders.

The court’s prosecutor, Fatou Bensouda, said in December 2019 there was “a reasonable basis to believe that war crimes have been or are being committed in the West Bank, including East Jerusalem, and the Gaza Strip.”

She named both the Israeli Defense Forces and armed Palestinian groups such as Hamas as possible perpetrators.

She said she intended to open an investigation — as soon as judges ruled on whether the situation fell under the court’s jurisdiction or not.

In a majority ruling published Friday night, the judges said it does.

“The Court’s territorial jurisdiction in the Situation in Palestine … extends to the territories occupied by Israel since 1967, namely Gaza and the West Bank, including East Jerusalem,” they said.

That Palestine’s status under international law is still uncertain does not matter, the judges said, as it has been admitted to membership of parties to the court.

In a reaction, Human Rights Watch called the decision “pivotal” and said it “finally offers victims of serious crimes some real hope for justice after a half century of impunity,” said Balkees Jarrah, associate international justice director.

“It’s high time that Israeli and Palestinian perpetrators of the gravest abuses – whether war crimes committed during hostilities or the expansion of unlawful settlements – face justice.”

Israeli Prime Minister Benjamin Netanyahu reacted, saying “the court is ignoring the real war crimes and instead is pursuing Israel, a country with a strong democratic regime, that sanctifies the rule of law, and is not a member of the tribunal.”

He added Israel would “protect all of our citizens and soldiers” from prosecution.

“The court in its decision impairs the right of democratic countries to defend themselves,” Netanyahu said.

The Palestinian Foreign Ministry said in a statement that it was a “historic day for the principle of accountability.”

Sami Abu Zuhri, a Hamas official, described the decision as “an important development that contributes in protecting the Palestinian people.”

“We urge the international court to launch an investigation into Israeli war crimes against the Palestinian people,” said Abu Zuhri, who is currently outside Gaza.

The United States has “serious concerns” about the ICC’s effort to assert jurisdiction over Israeli personnel in the Palestinian territories, U.S. State Department spokesman Ned Price said, adding the U.S. government was reviewing the ruling.

ICC prosecutor Bensouda was expected to react later on Friday.

The Trump administration had vehemently opposed the ICC and its mission. Jamil Dakwar, director of the American Civil Liberties Union’s Human Rights Program, said U.S. President Joe Biden should do nothing to undermine the ICC’s independence.

“It’s important to remember that the ICC investigation would also target Palestinian perpetrators of war crimes in the context of hostilities between Israel and Palestinian armed groups, especially in the Gaza Strip,” Dakwar said on Twitter.

(Reporting by Toby Sterling, Anthony Deutsch, Stephanie van den Berg, Ari Rabinovitch, Stephen Farrell, Nidal al-Mughrabi, Arshad Mohammed, Humeyra Pamuk and Simon Lewis; Editing by Aurora Ellis and Daniel Wallis)

Crossing the COVID chasm between Israel and the Palestinian Territories

By Zainah El-Haroun and Adel Abu Nimeh

JERICHO, West Bank (Reuters) – As a Palestinian living in Jerusalem, Ismail Daiq is used to negotiating the dividing lines between communities: the daily commute to his Jordan Valley date farm involves crossing a checkpoint on his way home.

Now the coronavirus pandemic has created another fault line for him to navigate: the stark difference between access to vaccines in Israel and in the Palestinian territories.

Living within the Israeli health system, Daiq, 62, has already received his second COVID-19 vaccination in a country that is a leader in the world’s inoculation drive.

But his Palestinian siblings and 95-year-old mother in Jericho are still awaiting a vaccine rollout that has only just begun under the Palestinian Authority, which exercises limited sovereignty in the Israeli-occupied West Bank.

Daiq is eligible for vaccination because he became a Jerusalem resident two decades ago when he married a woman from the city.

The rest of his family, friends and employees do not qualify, because they only have West Bank identity papers that do not let them pass through the Israeli checkpoints that control entry to the city.

So when the date farmer travels each day into the Palestinian territories, he is uncomfortably aware that while he feels safe, his loved ones are still at risk from the virus.

“I feel guilty, I feel very sad, because I want all my family safe,” Daiq told Reuters.

“When you see that you can get these services, the vaccination, and all of the family, they can’t get this vaccination, you feel that there is a difference between you and your family.”

Although Israel and the Palestinian Authority coordinate on security issues, political relations have foundered. Negotiations last broke down in 2014.

In January, the Palestinian Foreign Ministry accused Israel of ignoring its duties as an occupying power by not including Palestinians in the West Bank and Gaza Strip in their inoculation program.

Israeli officials have said that this is the job of the Palestinian authorities.

“If it is the responsibility of the Israeli health minister to take care of the Palestinians, what exactly is the responsibility of the Palestinian health minister?” Israeli Health Minister Yuli Edelstein told the BBC last month.

While Israel has so far vaccinated a third of its 9 million citizens, the Palestinian Authority received its first batch of 2,000 vaccines – supplied by Israel – on Monday. West Bank health workers received the first shots.

Daiq said he tried to avoid the subject with his family, because his mother kept asking him when she would be inoculated.

His brother Ibrahim, 60, said that he wished good health to “every person on this land” but that there was a sense of unfairness among Palestinians.

“Because of this, my natural rights as a human being, me and the rest of the people living in the West Bank and Gaza, considering we are a country living under occupation, we should also have the right to benefit from this vaccination.”

The West Bank, where 3.1 million Palestinians live, has reported 101,221 coronavirus cases, with 1,271 deaths. Gaza, with a population of two million, has registered more than 51,000 cases with 523 deaths. Israel has reported 663,665 coronavirus cases and 4,888 deaths.

(Reporting by Zainah El-Haroun and Adel Abu Nimeh in Jericho; Additional reporting by Estelle Shirbon in London; Editing by Mike Collett-White)

Israel and Kosovo establish diplomatic relations in virtual ceremony

By Rami Ayyub

JERUSALEM (Reuters) – Israel and Kosovo established diplomatic relations on Monday, via online links due to the coronavirus crisis, under a U.S.-brokered deal that includes a pledge by the Muslim-majority country to open an embassy in Jerusalem.

Israel sees its new ties with the tiny Balkan country as part of its broader normalization with Arab and Muslim countries under agreements sponsored by former U.S. President Donald Trump.

Trump announced the two countries’ ties in September as a side deal to an economic agreement between Kosovo and Serbia. As part of the deal, Serbia, which has ties with Israel, also agreed to open an embassy in Jerusalem.

During a signing ceremony held via Zoom video conference, Israeli Foreign Minister Gabi Ashkenazi said the new ties were “historic” and “reflect a change in the region, and in the Arab (and) Muslim world’s relationship with Israel.”

Ashkenazi said he had received an official request from Kosovo to establish a Jerusalem embassy, which Israeli officials hope will open by end-March.

Only two countries – the United States and Guatemala – have embassies in Jerusalem. Others, including Malawi and Honduras, have pledged to make the move.

The status of Jerusalem is one of the thorniest obstacles to forging a peace deal between Israel and the Palestinians, who with broad international backing want East Jerusalem, captured by Israel in the 1967 Middle East war, as their capital.

The ceremony included the unveiling of a commemorative plaque that will be placed at the entrance to Kosovo’s embassy in Jerusalem upon opening, Israel’s foreign ministry said.

Kosovo Foreign Minister Meliza Haradinaj-Stublla said Kosovo and Israel share a “historic bond” and had both “witnessed a long and challenging path to existing as a people and becoming states.”

Kosovo declared independence from Serbia in 2008, almost a decade after a guerrilla uprising by its ethnic Albanian majority.

Haradinaj-Stublla said she had spoken in recent days with U.S. Secretary of State Antony Blinken, who she said voiced President Joe Biden’s support for Kosovo’s new relations with Israel and economic agreement with Serbia.

(Editing by Giles Elgood)

Kushner, Berkowitz nominated for Nobel peace prize for Israel deal

By Steve Holland

WASHINGTON (Reuters) – Former White House senior adviser Jared Kushner and his deputy, Avi Berkowitz, were nominated on Sunday for the Nobel Peace Prize for their role in negotiating four normalization deals between Israel and Arab nations known as the “Abraham Accords.”

The deals were announced in a four-month span between mid-August and mid-December and were the most significant diplomatic breakthroughs in the Middle East in 25 years as the region girds for a prolonged confrontation with Iran.

Nominating the pair of former deputies to then-President Donald Trump was American attorney Alan Dershowitz, who was eligible to do so in his capacity as a professor emeritus of Harvard Law School.

Kushner and Berkowitz were key figures in negotiating deals between Israel and the United Arab Emirates, Bahrain, Sudan and Morocco.

In a statement, Kushner said he was honored to be nominated for the prize, which will be awarded in October.

Some lawmakers have complained about the Morocco deal because, to win the nation’s agreement, the United States recognized its sovereignty over the disputed Western Sahara.

(Reporting by Steve Holland; Editing by Clarence Fernandez)

EU warns it could block vaccine exports, wields legal threat at drugmakers

By John Chalmers and Philip Blenkinsop

BRUSSELS (Reuters) – Europe’s fight to secure COVID-19 vaccine supplies intensified on Thursday when the European Union warned drug companies such as AstraZeneca that it would use all legal means or even block exports unless they agreed to deliver shots as promised.

The EU, whose member states are far behind Israel, the United Kingdom and the United States in rolling out vaccines, is scrambling to get supplies just as the West’s biggest drugmakers slow deliveries to the bloc due to production problems.

As vaccination centers in Germany, France and Spain cancelled or delayed appointments, the EU publicly rebuked Anglo-Swedish drugmaker AstraZeneca for failing to deliver and even asked if it could divert supplies from Britain.

European Council President Charles Michel said in a letter to four EU leaders that the EU should explore legal means to ensure supplies of COVID-19 vaccines it contracted to buy if negotiations with companies over delayed deliveries are unsuccessful.

“If no satisfactory solution can be found, I believe we should explore all options and make use of all legal means and enforcement measures at our disposal under the Treaties,” Michel said in the Jan. 27 letter.

EU rules on monitoring and authorizing exports of COVID-19 vaccines in the 27-nation bloc could lead to exports being blocked if they violated existing contracts between the vaccine maker and the EU, an EU official said.

The European Commission is to lay out the criteria under which such exports would be evaluated on Friday.

VACCINE CRUNCH

The swiftest mass vaccination drive in history is stoking tensions across the world as big powers buy up doses in bulk and poorer nations try to navigate a financial and diplomatic minefield to collect whatever supplies are left.

Israel is by far the world leader on vaccine rollout per head of population, followed by the United Arab Emirates, the United Kingdom, Bahrain and the United States. Behind them are Italy, Germany, France, China and Russia.

The African Union (AU) has secured another 400 million doses of the AstraZeneca COVID-19 vaccine, a regional health leader said on Thursday, in a push to immunize 60% of the continent’s population over three years.

Under fire from the EU, AstraZeneca CEO Pascal Soriot said the EU was late to strike a supply contract so the company did not have enough time to iron out production problems at a vaccine factory run by a partner in Belgium.

Tensions have risen as both New York-based Pfizer and AstraZeneca, headquartered in Cambridge, England, have had production problems.

Britain, which has repeatedly touted its lead in the vaccine rollout race since leaving the EU’s orbit on Jan. 1, said its deliveries must be honored.

“I think we need to make sure that the vaccine supply that has been bought and paid for, procured for those in the UK, is delivered,” Minister for the Cabinet Office Michael Gove told LBC Radio.

Just a day ahead of a decision by European regulators on whether to approve the drugmaker’s shot, Germany’s vaccine committee said AstraZeneca’s vaccine should only be given to people aged between 18 and 64.

“There are currently insufficient data available to assess the vaccine efficacy from 65 years of age,” the committee, also known as Stiko, said in a draft resolution made available by the health ministry on Thursday.

Britain’s Johnson said health authorities in Britain believed the vaccine was safe and worked across all age groups.

APPOINTMENTS CANCELLED

In the northern French region of Hauts-de-France, France’s second-most-densely-populated region, several vaccination centers were no longer taking appointments for a first jab. In several other French regions, some online appointment platforms closed booking options.

Spain’s Madrid region has ceased first vaccinations for at least this week and next and was using the few doses it has to administer second shots to those who have had the first one, said deputy regional government chief Ignacio Aguado.

Germany’s most populous state, North Rhine-Westphalia, last week postponed opening its vaccination centers until Feb. 8, while the state of Brandenburg has also had to push back vaccination appointments originally scheduled for the end of January due to delivery delays.

AstraZeneca is prepared to publish the delivery contract it has with the European Union and aims on Friday to make proposals to the European Commission on which sensitive parts to black out, the Frankfurter Allgemeine reported.

The newspaper quoted an EU source as saying that while AstraZeneca would not be able to deliver the 80 million doses expected for the first quarter, volumes should significantly exceed the 31 million doses that had earlier been reported.

(Reporting by Emma Thomasson and Paul Carrel in Berlin and Matthias Blamont in Paris and Kate Holton, Paul Sandle and Alistair Smout in London; writing by Guy Faulconbridge; editing by Keith Weir and Nick Macfie)